Is Rocket Lab Stock a Buy After Its Big Contract Win?

Rocket Lab will participate in the U.S. Space Force’s NITE-STAR program with a $981M contract ceiling, but the expected average payoff per winning task order is only about $6.5M per year. With Rocket Lab already pulling in nearly $770M annually, the program is likely to add less than 1% to revenue. The headline opportunity looks sizeable, but the article frames it as unlikely to move RKLB’s stock materially given valuation (~60x sales) and ongoing unprofitability.

Analysis

This is better viewed as a procurement qualification event than an earnings event. For RKLB, the market is likely to over-interpret “on the team” as if it were a meaningful backlog add, when the more relevant variable is how much task-order share it can actually convert versus larger defense incumbents with deeper cleared infrastructure and existing program relationships. In the next 1-5 trading days, the risk is a reflexive pop fading as investors reprice the announcement from “platform validation” to “small optionality.”

Competitive dynamics matter more than the nominal ceiling: the economics of these programs tend to concentrate in incumbents that already have capture teams, compliance overhead, and adjacent contract vehicles. That argues for LMT and NOC as better positioned to absorb follow-on defense workload if this architecture expands, while VSAT can benefit only if the network/communications layer becomes a larger portion of spend. For RKLB, the second-order benefit is reputational — improved win probability on future space-domain budgets — but that is a 6-18 month story and only matters if it translates into recurring task orders or larger sole-source wins.

The contrarian read is that the market may already understand the revenue is immaterial, but still underestimate how much this weakens the bull case built on defense “call option” narratives. If RKLB can’t convert these badges into a visible ramp in gross profit dollars, the stock remains a multiple story, and multiples compress quickly when enthusiasm outruns bookings. Falsifiers: a materially higher-than-expected annual task-order run-rate, a sequence of adjacent Space Force awards, or a guidance/backlog step-up on the next earnings call.

Key Decisions for Investors

• Tactically fade any opening strength in RKLB over the next 1-3 sessions; use a small short or put spread only if the stock gaps up on the announcement. Risk/reward is attractive only if the market prices this as meaningful revenue upside; cover if management quantifies >$15-20M annual task-order potential or provides backlog commentary that changes the math.